Acarbose and Lanreotide Acetate: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 10, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Acarbose
Lanreotide Acetate
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You've been prescribed acarbose (a diabetes pill that slows how fast sugar is absorbed from your food) along with lanreotide. Lanreotide can change how your body handles blood sugar because it affects the hormones (insulin and glucagon) that keep your sugar balanced. This means your blood sugar could swing more than usual, going too high or too low, and it may be harder to predict.
The good news is this is very manageable. Your care team can check your blood sugar more often and adjust your diabetes medicine as needed so you stay in a safe range. Keep taking both medicines as prescribed and talk with your pharmacist or doctor about how often to test.
Effect: Concurrent use of the somatostatin analog lanreotide with acarbose may impair glucose regulation, causing either hyperglycemia or hypoglycemia.
Mechanism: Somatostatin analogs suppress secretion of both insulin and glucagon, disrupting glycemic homeostasis (a PD interaction, not PK; neither drug's metabolism is the driver here).
- Direction: unpredictable glycemic control; severe hyperglycemia and hypoglycemia both reported
- Onset: unspecified
- Evidence: theoretical
- Severity: major
Management: Optimize antidiabetic therapy in poorly-controlled patients before initiating lanreotide. Anticipate acarbose dose individualization and intensify blood glucose monitoring.
What happens
An increased risk of hypoglycemia and impaired glucose regulation
Interaction Deep Dive
The secretion of both insulin and glucagon is suppressed by somatostatin analogs3. As a result, blood glucose levels may rise severely. Before initiating the somatostatin analog, antidiabetic therapy should be optimized in patients whose diabetes is poorly controlled4. It may be necessary to adjust the dose of the antidiabetic agent and to monitor glucose more frequently125.
Why it happens (mechanism)
Altered glucose metabolism
How to manage this interaction
This interaction is manageable with attention from your care team.
- Keep taking both medicines exactly as prescribed unless your doctor tells you otherwise.
- Your team may check your blood sugar more often, especially when lanreotide is started or changed.
- Your acarbose dose may need to be adjusted and individualized by your care team based on your readings.
- If your diabetes is not well controlled now, your doctor will likely want to get it steadier before starting lanreotide.
Tell your pharmacist or doctor about symptoms of low blood sugar (shakiness, sweating, confusion) or high blood sugar (excess thirst, frequent urination).
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Acarbose and Lanreotide Acetate together?
Lanreotide can disrupt how your body controls blood sugar while you take acarbose, so expect more frequent glucose checks and possible dose tweaks. Keep taking both as prescribed and coordinate monitoring with your care team. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Acarbose and Lanreotide Acetate interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Acarbose and Lanreotide Acetate interaction managed?
This interaction is manageable with attention from your care team. Keep taking both medicines exactly as prescribed unless your doctor tells you otherwise. Your team may check your blood sugar more often, especially when lanreotide is started or changed. Your acarbose dose may need to be adjusted and individualized by your care team based on your readings. If your diabetes is not well controlled n… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Acarbose or Lanreotide Acetate need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (5)
- Product Information: TOUJEO(R) subcutaneous injection, insulin glargine subcutaneous injection. sanofi-aventis (per manufacturer), Bridgewater, NJ, 2015. DailyMed
- Product Information: Tresiba subcutaneous injection solution, insulin degludec subcutaneous injection solution. Novo Nordisk A/S (per EMA), Bagsvaerd, Denmark, 2013. DailyMed
- Product Information: Sandostatin(R) LAR Depot intramuscular injection suspension, octreotide acetate intramuscular injection suspension. Novartis Pharmaceuticals Corporation (per FDA), East Hanover, NJ, 2014.
- Product Information: SIGNIFOR(R) LAR intramuscular injection suspension, pasireotide intramuscular injection suspension. Novartis Pharmaceuticals Corporation (per FDA), East Hanover, NJ, 2014.
- Product Information: ADMELOG(R) subcutaneous, intravenous injection, insulin lispro subcutaneous, intravenous injection. sanofi-aventis US LLC (per DailyMed), Bridgewater, NJ, 2023. DailyMed
Keep reading about Acarbose
Keep reading about Lanreotide Acetate
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist